Overview

A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This study is designed to show how well tobramycin inhalation powder works and how safe it is when produced by a modified manufacturing process
Phase:
Phase 3
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Tobramycin